HyperMabs is a biopharmaceutical company that designs and develops
innovative monoclonal antibody-based therapeutics for life threatening
diseases including COVID-19. We believe in connecting rigorous science with
our innate sense of urgency to rapidly generate breakthrough therapies for
patients in need of a better quality of life. Our highly qualified team of drug
developers and company builders has a track record of advancing complex
biologics from discovery through clinical trials.

Biotechnology

HyperMabs Inc.

Org chart

Teams

Offices

Similar companies